News Search Results
Jul 08, 2025, 23:27 ET First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418
2025 /PRNewswire/ -- Duality Biotherapeutics' ("DualityBio", HKEX:09606) partner Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced the first patient has been dosed in the Phase 1 portion of a Phase 1/2 clinical
More news about: Duality Biotherapeutics
Jul 08, 2025, 23:14 ET First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418
2025 /PRNewswire/ -- Duality Biotherapeutics' ("DualityBio", HKEX:09606) partner Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced the first patient has been dosed in the Phase 1 portion of a Phase 1/2 clinical
More news about: Duality Biotherapeutics
Jul 08, 2025, 19:00 ET U.S. FDA Grants Orphan Drug Designation to Adcentrx Therapeutics' ADRX-0405 STEAP1 ADC for Gastric Cancer
Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, today announced that the U.S.
More news about: Adcentrx Therapeutics
Jul 08, 2025, 16:20 ET Centivax Raises Oversubscribed $45 Million Series A Led by Future Ventures to Advance Universal Flu Vaccine into Clinic and Expand Universal Immunity Portfolio
FRANCISCO, Calif., July 8, 2025 /PRNewswire/ -- Centivax, Inc., a biotechnology company engineering vaccines and therapies for durable, universal protection against highly diverse targets, today announced the close of an oversubscribed
More news about: Centivax
Jul 08, 2025, 16:05 ET Tyra Biosciences Announces Late-Breaking Poster Presentation on TYRA-300 Preclinical Results at ENDO 2025
July 8, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology,
More news about: Tyra Biosciences
Jul 08, 2025, 13:08 ET Rubin and Rudman Partners Joseph Bodoff and Rion Vaughan Named to 2025 Lawdragon 500 Leading Global Bankruptcy & Restructuring Lawyers
Rubin and Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin and Rudman
Jul 08, 2025, 12:00 ET Biotia Partners with Leading Korean Pharmaceutical Company to Advance Infectious Disease Diagnostics in Remote Regions -- Including in Space
QUEENS, N.Y., July 8, 2025 /PRNewswire/ -- Biotia, a biotechnology company pioneering the development of novel infectious disease diagnostics, today announced its selection as an awardee in the Humans in Space
More news about: Biotia, Inc.
Jul 08, 2025, 11:30 ET Colorectal Cancer Treatment Market Size is Projected to Reach USD 24.77 Billion, with a Robust 3.2% CAGR till 2031, Rising Prevalence of Cancer Boosts | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 08, 2025, 11:15 ET Fluorine-18 Market Size Projected to USD 2.54 Billion by 2031 with 4.7% CAGR, Experiences Growth with Rising Prevalence of Cancer | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 08, 2025, 11:10 ET FTRE Investors Have the Opportunity to Lead the Fortrea Holdings Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
from buy to hold. Among other things, the Jefferies Report cited perceived weaknesses in the Company's business model as a CRO amid pressure on biotechnology funding and suggested that the cost savings Fortrea expects to achieve by exiting the TSAs are "not as material as [o]ne [m]ight think," stating
More news about: Faruqi & Faruqi, LLP
Jul 08, 2025, 10:45 ET Dental Bone Graft and Substitutes Market to Hit USD 1,098.48 million by 2031 | Global Outlook & Forecast at 7.21% CAGR | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 08, 2025, 09:00 ET Cizzle Bio Submits NIH Grant Proposal with Premier Research Institutions to Advance Biomarker Blood Test for Lung Cancer
SAN ANTONIO, July 8, 2025 /PRNewswire/ -- Cizzle Bio, Inc., a biotechnology company pioneering innovative biomarker blood tests for early detection of lung and gastric cancers, has submitted a grant application to the National
More news about: Cizzle Bio
Jul 08, 2025, 09:00 ET Sensorium Therapeutics Receives FDA IND Clearance for SNTX-2643, a First-in-Class, Rapid-Acting Anxiolytic
About Sensorium Sensorium Therapeutics is a clinical–stage biotechnology company developing brain and mental health treatments that are derived from nature, mechanistically driven, clinically precise, and designed to
More news about: Sensorium Therapeutics, Inc
Jul 08, 2025, 09:00 ET Metabolon Announces a Quarter Century of Scientific Innovation, Industry Leadership, and Transformative Contributions to Life Science
measures. Trusted by Leading Organizations: Metabolon serves thousands of clients worldwide, including the majority of the top pharmaceutical, biotechnology, and academic institutions. Metabolon empowers these organizations to shorten development timelines, accelerate pipeline progression, and support
More news about: Metabolon, Inc.
Jul 08, 2025, 09:00 ET Metabolon Announces a Quarter Century of Scientific Innovation, Industry Leadership, and Transformative Contributions to Life Science
measures. Trusted by Leading Organizations: Metabolon serves thousands of clients worldwide, including the majority of the top pharmaceutical, biotechnology, and academic institutions. Metabolon empowers these organizations to shorten development timelines, accelerate pipeline progression, and support
More news about: Metabolon, Inc.
Jul 08, 2025, 08:30 ET Oncolytics Biotech® Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling Studies
website, that provides detailed clinical and translational data. About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized
More news about: Oncolytics Biotech® Inc.
Jul 08, 2025, 08:00 ET ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review
as its new Vice President, Labeling & Strategy. In this role, he will lead compliance and regulatory advisory services for pharmaceutical, biotechnology, medical device, and diagnostic companies.
More news about: ProPharma Group Holdings LLC
Jul 08, 2025, 08:00 ET Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America
solutions in healthcare using artificial intelligence and biotechnologies. With a focus on pushing the boundaries of what is possible in AI and biotechnology, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology. More information about
More news about: Avant Technologies Inc.
Jul 08, 2025, 07:30 ET Soligenix Corporate Update Letter - Key Highlights and Upcoming Milestones
procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will
More news about: SOLIGENIX, INC.
Jul 08, 2025, 02:00 ET Independent Meta-Analysis Shows SkylineDx's Merlin CP-GEP Assay Accurately Stratifies Patients for Sentinel Lymph Node Biopsy Selection
www.merlinmelanomatest.com About SkylineDx SkylineDx is a biotechnology company focused on research and development of molecular diagnostics in oncology, inflammatory and infectious diseases. SkylineDx uses its expertise
More news about: SkylineDx
Jul 07, 2025, 22:08 ET Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo)
biologic ZYMFENTRA® (infliximab-dyyb). Celltrion USA will continue to leverage Celltrion's unique heritage in biotechnology, supply chain excellence and best-in-class sales capabilities to improve access to high-quality biopharmaceuticals for U.S. patients. For more information,
More news about: Celltrion
Jul 07, 2025, 22:00 ET SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V
July 7, 2025 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced today that the China
More news about: SCG Cell Therapy Pte Ltd
Jul 07, 2025, 16:30 ET BIOVAXYS ENGAGES ENCLAVE CAPITAL LLC TO ACT AS AN AGENT IN BROKERED PRIVATE PLACEMENT OFFERING
receive the required regulatory approvals. With regards to BioVaxys' business, there are a number of risks that could affect the development of its biotechnology products, including, without limitation, the need for additional capital to fund clinical trials, its lack of operating history, uncertainty about
More news about: BioVaxys Technology Corp.
Jul 07, 2025, 16:05 ET INOVIO to Present at Upcoming Scientific Conference
MEETING, Pa., July 7, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious
More news about: INOVIO Pharmaceuticals, Inc.
Jul 07, 2025, 14:54 ET Global Industrial Enzyme Markets: Innovation, Impact, and Growth
"The global industrial enzyme market is experiencing rapid growth, driven by advances in biotechnology and increasing demand across sectors like food, biofuels, and textiles. These powerful biocatalysts are revolutionizing industrial processes with greater efficiency and sustainability."
More news about: BCC Research LLC